<?xml version="1.0"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:nw="http://www.newsweaver.ie">
<channel>
<title>UT Health News - 3-23-23 UT Health San Antonio</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/</link>
<atom:link href="https://academicexternal.us.newsweaver.com/uthealthnews/rss/rss.xml" rel="self" type="application/rss+xml" />
<description></description>
<language>en-us</language>
<pubDate>23 Mar 2023 09:46:03 EDT</pubDate>
<lastBuildDate>23 Mar 2023 09:46:03 EDT</lastBuildDate>
<docs>https://academicexternal.us.newsweaver.com/uthealthnews/rss.xml</docs>
<generator>Newsweaver</generator>
<managingEditor>communications@uthscsa.edu (University of Texas Health Science Center (UTHSCSA))</managingEditor>
<webMaster>support@newsweaver.ie (Newsweaver)</webMaster>
<ttl>60</ttl>
<nw:microsite>true</nw:microsite>
<item>
<title>Professor awarded $4.1M to combat opioid epidemic</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/1dyd46mc2u3?lang=en?rss=true</link>
<description>



Charles P. France, PhD, professor of pharmacology, received funding from the National Institutes of Health to research the compound methocinnamox. The drug “will work to both rescue people from opioid overuse and prevent relapse, but in a much more effective manner than either of the drugs that are currently available, naloxone and naltrexone,” France said.










</description>
<pubDate>14 Dec 2021 12:00:00 EST</pubDate>
<guid isPermaLink="false">554a5618038ed013226242302e9fc93e</guid>
<category>Feature Article</category>
<nw:synopsis>&amp;lt;p class="centered-only" style="text-align: center;"&amp;gt;&amp;lt;img align="middle" src="http://academicexternal.us.newsweaver.com/v3files/shard200/1000322/17/7fe439042c6a7e0d90ea3b.jpg" style="margin: 0px;" width="551" height="367" hspace="0" vspace="0" alt="" /&amp;gt;&amp;lt;/p&amp;gt;
&amp;lt;p&amp;gt;&amp;nbsp;&amp;lt;/p&amp;gt;
&amp;lt;p&amp;gt;&amp;lt;span style="font-size: 15px; font-family: Arial, Helvetica, sans-serif;"&amp;gt;Charles P. France, PhD, professor of pharmacology, received funding from the National Institutes of Health to research the compound methocinnamox. The drug&amp;nbsp;&amp;lt;/span&amp;gt;&amp;lt;span style="font-size: 15px;"&amp;gt;&amp;ldquo;will &amp;lt;/span&amp;gt;&amp;lt;span style="font-size: 15px; font-family: Arial, Helvetica, sans-serif;"&amp;gt;work to both rescue people from opioid overuse and prevent relapse, but in a much more effective manner than either of the drugs that are currently available, naloxone and naltrexone,&amp;lt;span style="font-size: 15px;"&amp;gt;&amp;rdquo;&amp;lt;/span&amp;gt; France said.&amp;lt;br /&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
&amp;lt;p&amp;gt;&amp;lt;!-- Read More Spacer --&amp;gt;&amp;lt;/p&amp;gt;
&amp;lt;p&amp;gt;&amp;lt;!-- Read More Spacer --&amp;gt;&amp;lt;/p&amp;gt;
&amp;lt;p&amp;gt;&amp;lt;!-- Read More Spacer --&amp;gt;&amp;lt;/p&amp;gt;
&amp;lt;p class="centered-only" style="text-align: center;"&amp;gt;&amp;lt;!-- Read More Spacer --&amp;gt;&amp;lt;/p&amp;gt;
</nw:synopsis>
<nw:fullStoryLinkText>Learn More</nw:fullStoryLinkText>
<nw:webAddress>https://news.uthscsa.edu/ut-health-san-antonio-professor-france-leads-novel-drug-discovery-research/</nw:webAddress>
</item>
<item>
<title>99% of senior medical students match to residencies</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/cafbwfrfen2?lang=en?rss=true</link>
<description>





Nearly 200 eager senior students from the Joe R. and Teresa Lozano Long School of Medicine learned where they will go for their medical residency training during the annual Match Day. Exceeding the national average, 99% of graduating medical students matched to residency programs of their choice — more than half will stay in Texas.


</description>
<pubDate>21 Mar 2023 12:00:00 EDT</pubDate>
<guid isPermaLink="false">0182749b63f75dc50bfd599f211a1de1</guid>
<category>Feature Article</category>
<nw:synopsis>&amp;lt;p&amp;gt;&amp;nbsp;&amp;lt;/p&amp;gt;
&amp;lt;p class="centered-only" style="text-align: center;"&amp;gt;&amp;lt;img align="middle" src="http://academicexternal.us.newsweaver.com/v3files/shard200/1000322/77/9139ee5e1560f91ba3b2a2.jpg" style="margin: 0px;" width="550" height="413" hspace="0" vspace="0" alt="" /&amp;gt;&amp;lt;/p&amp;gt;
&amp;lt;p&amp;gt;&amp;nbsp;&amp;lt;/p&amp;gt;
&amp;lt;p&amp;gt;&amp;lt;span style="font-size: 15px;"&amp;gt;Nearly 200 eager senior students from the Joe R. and Teresa Lozano Long School of Medicine learned where they will go for their medical residency training during the annual Match Day. Exceeding the national average, 99% of graduating medical students matched to residency programs of their choice &amp;mdash; more than half will stay in Texas.&amp;lt;br /&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
</nw:synopsis>
<nw:fullStoryLinkText>Read More</nw:fullStoryLinkText>
<nw:webAddress>https://news.uthscsa.edu/long-school-of-medicine-seniors-match-to-residencies-on-match-day/</nw:webAddress>
</item>
<item>
<title>Lower melanoma recurrence with new immunotherapy regimen, study finds</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/7wtnxdwk1lz?lang=en?rss=true</link>
<description>A new study published in the New England Journal of Medicine found that advanced stage melanoma study participants who received the immunotherapy drug pembrolizumab — before and after surgery — had a reduced risk of recurring cancer compared to participants who received the drug only after surgery.

</description>
<enclosure url="http://academicexternal.us.newsweaver.com/v3files/shard200/1000322/d7/a1c52dbd26bb17dc868285.jpg" type="image/jpeg" length="95232"/>
<pubDate>23 Jan 2023 12:00:00 EST</pubDate>
<guid isPermaLink="false">c93ef54a5e0ff65e68e72bb9d25adb37</guid>
<category>Feature Article</category>
<nw:synopsis>&amp;lt;p&amp;gt;&amp;lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: 15px;"&amp;gt;A new study published in the &amp;lt;em&amp;gt;New England Journal of Medicine&amp;lt;/em&amp;gt; found that advanced stage melanoma study participants who received the immunotherapy drug pembrolizumab &amp;mdash; before and after surgery &amp;mdash; had a reduced risk of recurring cancer compared to participants who received the drug only after surgery.&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
</nw:synopsis>
<nw:synopsisCaption>Professional head shot of Dr. Amelie Ramirez in a black top.</nw:synopsisCaption>
<nw:synopsisImage>http://academicexternal.us.newsweaver.com/v3files/shard200/1000322/d7/a1c52dbd26bb17dc868285.jpg</nw:synopsisImage>
<nw:fullStoryLinkText>Read More</nw:fullStoryLinkText>
<nw:webAddress>https://news.uthscsa.edu/study-results-show-immunotherapy-before-and-after-surgery-for-advanced-melanoma-lowers-recurrence-risk-2/</nw:webAddress>
</item>
<item>
<title>Novel drug makes mice slim even on sugary, fatty diet</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/1813gd2kwt2?lang=en?rss=true</link>
<description>UT Health San Antonio scientists have developed a drug that prevents weight gain and adverse liver changes in mice fed a high-sugar, high-fat Western diet. “A drug that can reduce the risk of cardiometabolic diseases such as heart attack and stroke, and also reduce the incidence of liver cancer, which can follow fatty liver disease, will make a huge impact,” said Madesh Muniswamy, PhD.

</description>
<enclosure url="http://academicexternal.us.newsweaver.com/v3files/shard200/1000322/47/9c9a1bcb3b82b25b55fa57.jpg" type="image/jpeg" length="61440"/>
<pubDate>22 Feb 2022 12:00:00 EST</pubDate>
<guid isPermaLink="false">d1cad58e931a7303d0d2ffc022e0c163</guid>
<category>Feature Article</category>
<nw:synopsis>&amp;lt;p&amp;gt;&amp;lt;span style="font-size: 15px;"&amp;gt;UT Health San Antonio scientists have developed a drug that prevents weight gain and adverse liver changes in mice fed a high-sugar, high-fat Western diet. &amp;ldquo;A drug that can reduce the risk of cardiometabolic diseases such as heart attack and stroke, and also reduce the incidence of liver cancer, which can follow fatty liver disease, will make a huge impact,&amp;rdquo; said Madesh Muniswamy, PhD.&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
</nw:synopsis>
<nw:synopsisImage>http://academicexternal.us.newsweaver.com/v3files/shard200/1000322/47/9c9a1bcb3b82b25b55fa57.jpg</nw:synopsisImage>
<nw:fullStoryLinkText>Read More</nw:fullStoryLinkText>
<nw:webAddress>https://news.uthscsa.edu/novel-drug-makes-mice-slim-even-on-sugary-fatty-diet-3/</nw:webAddress>
</item>
<item>
<title>A cold room, not a warm bath, encourages sleep</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/c7r4vie9ikc?lang=en?rss=true</link>
<description>Some may find it difficult to adjust to daylight saving time and struggle to fall asleep. Neurologist Okeanis Vaou, MD, says falling asleep is dependent on a number of biological functions, such as body temperature, digestion and blood pressure, but small adjustments can help bring on sleep.


</description>
<enclosure url="http://academicexternal.us.newsweaver.com/v3files/shard200/1000322/2d/ace9e95c157b10cb7bad45.jpg" type="image/jpeg" length="61440"/>
<pubDate>09 Jan 2023 12:00:00 EST</pubDate>
<guid isPermaLink="false">c2deba6a7972f4183b0402b68b25687b</guid>
<category>Patient Care</category>
<nw:synopsis>&amp;lt;p&amp;gt;&amp;lt;span style="font-size: 15px;"&amp;gt;Some may find it difficult to adjust to daylight saving time and struggle to fall asleep. Neurologist Okeanis Vaou, MD, says falling asleep is dependent on a number of biological functions, such as body temperature, digestion and blood pressure, but small adjustments can help bring on sleep.&amp;lt;br /&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
</nw:synopsis>
<nw:synopsisImage>http://academicexternal.us.newsweaver.com/v3files/shard200/1000322/2d/ace9e95c157b10cb7bad45.jpg</nw:synopsisImage>
<nw:fullStoryLinkText>Learn More</nw:fullStoryLinkText>
<nw:webAddress>https://news.uthscsa.edu/a-cold-room-not-a-warm-bath-encourages-sleep/</nw:webAddress>
</item>
<item>
<title>5 types of household items to avoid if you have a chemical intolerance</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/7tt3o0mz15l?lang=en?rss=true</link>
<description>Before you tackle your spring cleaning list, have you considered if the products you use affect you? Claudia S. Miller, MD, MS, discusses chemical intolerance, how to determine if you might have one and which types of household items to avoid if you do.


</description>
<enclosure url="http://academicexternal.us.newsweaver.com/v3files/shard200/1000322/01/282ab4e653f46a38226254.jpg" type="image/jpeg" length="70656"/>
<pubDate>29 Nov 2022 12:00:00 EST</pubDate>
<guid isPermaLink="false">3dc6d27ea129889e47daf28306589d3d</guid>
<category>Patient Care</category>
<nw:synopsis>&amp;lt;p&amp;gt;&amp;lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: 15px;"&amp;gt;&amp;lt;span class="field-content"&amp;gt;Before you tackle your spring cleaning list, have you considered if the products you use affect you? Claudia S. Miller, MD, MS, discusses chemical intolerance, how to determine if you might have one and which types of household items to avoid if you do.&amp;lt;br /&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
</nw:synopsis>
<nw:synopsisImage>http://academicexternal.us.newsweaver.com/v3files/shard200/1000322/01/282ab4e653f46a38226254.jpg</nw:synopsisImage>
<nw:fullStoryLinkText>Learn More</nw:fullStoryLinkText>
<nw:webAddress>https://news.uthscsa.edu/5-types-of-household-items-to-avoid-if-you-have-a-chemical-intolerance/</nw:webAddress>
</item>
<item>
<title>Salute Magazine: A head start in public health</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/191errrgv2m?lang=en?rss=true</link>
<description>



Dental and dental hygiene students support access to oral health care through a required rotation with the San Antonio Metropolitan Health District’s Oral Health Program, which provides a glimpse at a career in public health.

</description>
<pubDate>23 Jan 2023 12:00:00 EST</pubDate>
<guid isPermaLink="false">54624c7c952df4a9bb7c346e176209a7</guid>
<category>Patient Care</category>
<nw:synopsis>&amp;lt;p class="centered-only" style="text-align: center;"&amp;gt;&amp;lt;span style="font-size: 15px;"&amp;gt;&amp;lt;img align="middle" src="http://academicexternal.us.newsweaver.com/v3files/shard200/1000322/09/fa1a0a67b79633bacf26af.png" style="margin: 0px;" width="551" height="329" hspace="0" vspace="0" alt="" /&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
&amp;lt;p&amp;gt;&amp;nbsp;&amp;lt;/p&amp;gt;
&amp;lt;p&amp;gt;&amp;lt;span style="font-size: 15px;"&amp;gt;Dental and dental hygiene students support access to oral health care through a required rotation with the San Antonio Metropolitan Health District&amp;rsquo;s Oral Health Program, which provides a glimpse at a career in public health.&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
</nw:synopsis>
<nw:synopsisCaption>A research team in white lab coats looks at scans of a brain on a computer screen.</nw:synopsisCaption>
<nw:fullStoryLinkText>Read More</nw:fullStoryLinkText>
<nw:webAddress>https://magazines.uthscsa.edu/schools/2022/12/16/a-head-start-in-public-health/</nw:webAddress>
</item>
<item>
<title>April 1: Community Health Fair</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/1abanvy8z18?lang=en?rss=true</link>
<description></description>
<pubDate>05 Sep 2022 12:00:00 EDT</pubDate>
<guid isPermaLink="false">4aacb2a2f544f0a56a641528aa0a609c</guid>
<category>Events</category>
<nw:fullStoryLinkText>Learn More</nw:fullStoryLinkText>
<nw:webAddress>https://events.uthscsa.edu/event/community_health_fair</nw:webAddress>
</item>
<item>
<title>April 1: Viva Science SA!</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/s6dt9dd06hf?lang=en?rss=true</link>
<description></description>
<pubDate>16 Nov 2022 12:00:00 EST</pubDate>
<guid isPermaLink="false">5da61f598c974baf4bcc87db23fd5aca</guid>
<category>Events</category>
<nw:fullStoryLinkText>Learn More</nw:fullStoryLinkText>
<nw:webAddress>https://events.uthscsa.edu/event/Viva_Science_SA?utm_campaign=widget&amp;utm_medium=widget&amp;utm_source=University+of+Texas+Health+Science+Center+at+San+Antonio</nw:webAddress>
</item>
<item>
<title>April 1: Gear Up Against Kids Cancer bike ride</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/1htqomtx6zk?lang=en?rss=true</link>
<description></description>
<pubDate>07 Feb 2023 12:00:00 EST</pubDate>
<guid isPermaLink="false">548811a715820d1c226b30f8fa32104a</guid>
<category>Events</category>
<nw:fullStoryLinkText>Register Now</nw:fullStoryLinkText>
<nw:webAddress>https://events.uthscsa.edu/event/gear_up_against_kids_cancer_bike_ride</nw:webAddress>
</item>
<item>
<title>April 1: Give Cancer the Boot: Survivorship 5K Run/Walk</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/1z8to3dd83h?lang=en?rss=true</link>
<description></description>
<pubDate>07 Feb 2023 12:00:00 EST</pubDate>
<guid isPermaLink="false">0509c590cb45b67a416fa2a997f431b4</guid>
<category>Events</category>
<nw:fullStoryLinkText>Register Now</nw:fullStoryLinkText>
<nw:webAddress>https://events.uthscsa.edu/event/give_cancer_the_boot_survivorship_5k_runwalk</nw:webAddress>
</item>
<item>
<title>April 3: IIMS Community Engagement Small Project Grant deadline</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/134rq72mls5?lang=en?rss=true</link>
<description></description>
<pubDate>07 Feb 2023 12:00:00 EST</pubDate>
<guid isPermaLink="false">b2a0ac8ae065955d33ae3e50522861a2</guid>
<category>Events</category>
<nw:fullStoryLinkText>Learn More</nw:fullStoryLinkText>
<nw:webAddress>https://news.uthscsa.edu/application-deadline-extended-for-community-engagement-small-project-grants/</nw:webAddress>
</item>
<item>
<title>KSAT 12: Medical oncologist with UT Health San Antonio talks colorectal cancer with GMSA@9</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/1vziy2vrn32?lang=en?rss=true</link>
<description>“...Some signs to look out for are changes in bowel habits, bleeding in the stool or rectal bleeding, abdominal pain, discomfort, cramping, inability to have a complete bowel movement, feelings of weakness or fatigue and unexplained weight loss.” — Shruti Pandita, MD, Department of Gastrointestinal and Hematology Oncology


</description>
<pubDate>05 Oct 2022 12:00:00 EDT</pubDate>
<guid isPermaLink="false">d4a9175e3b4d4331590f81a8d401ba54</guid>
<category>In the News</category>
<nw:synopsis>&amp;lt;p&amp;gt;&amp;lt;span style="font-size: 15px; font-family: Arial, Helvetica, sans-serif;"&amp;gt;&amp;ldquo;...Some signs to look out for are changes in bowel habits, bleeding in the stool or rectal bleeding, abdominal pain, discomfort, cramping, inability to have a complete bowel movement, feelings of weakness or fatigue and unexplained weight loss.&amp;rdquo; &amp;mdash; Shruti Pandita, MD, Department of Gastrointestinal and Hematology Oncology&amp;lt;br /&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
</nw:synopsis>
<nw:fullStoryLinkText>Watch Now</nw:fullStoryLinkText>
<nw:webAddress>https://www.youtube.com/watch?v=VYRjvFD3JRE</nw:webAddress>
</item>
<item>
<title>MSN.com: The Ozempic craze: San Antonio doctor talks popular weight loss drug</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/1mhmw266g3e?lang=en?rss=true</link>
<description>“If someone is at a perfectly good weight, but still uncomfortable with their body, these drugs are not for them.” — Carolina Solis-Herrera, MD, Division of Diabetes


</description>
<pubDate>06 Feb 2023 12:00:00 EST</pubDate>
<guid isPermaLink="false">62dede915fe61c191a72d1a73539993e</guid>
<category>In the News</category>
<nw:synopsis>&amp;lt;p&amp;gt;&amp;lt;span style="font-family: Arial, Helvetica, sans-serif; font-size: 15px;"&amp;gt;&amp;ldquo;If someone is at a perfectly good weight, but still uncomfortable with their body, these drugs are not for them.&amp;rdquo; &amp;mdash; Carolina Solis-Herrera, MD, Division of Diabetes&amp;lt;br /&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
</nw:synopsis>
<nw:fullStoryLinkText>Read More</nw:fullStoryLinkText>
<nw:webAddress>https://www.msn.com/en-us/health/nutrition/the-ozempic-craze-san-antonio-doctor-talks-popular-weight-loss-drug/ar-AA18Iy48</nw:webAddress>
</item>
<item>
<title>Community Impact: SXSW EDU – Speakers stress early intervention, naloxone access to curb drug abuse</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/1mvvcj4xf6p?lang=en?rss=true</link>
<description>“Fentanyl is 100 times more potent than morphine and 50 times more potent than heroin.” — Lisa M. Cleveland, PhD, APRN, School of Nursing


</description>
<pubDate>19 Oct 2022 12:00:00 EDT</pubDate>
<guid isPermaLink="false">8cce55810925076f1c367474885c267d</guid>
<category>In the News</category>
<nw:synopsis>&amp;lt;p&amp;gt;&amp;lt;span style="font-size: 13px; font-family: Arial, Helvetica, sans-serif;"&amp;gt;&amp;lt;span style="font-size: 15px;"&amp;gt;&amp;ldquo;Fentanyl is 100 times more potent than morphine and 50 times more potent than heroin.&amp;rdquo; &amp;mdash; Lisa M. Cleveland, PhD, APRN, School of Nursing&amp;lt;/span&amp;gt;&amp;lt;br /&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/p&amp;gt;
</nw:synopsis>
<nw:fullStoryLinkText>Read More</nw:fullStoryLinkText>
<nw:webAddress>https://communityimpact.com/san-antonio/north-san-antonio/sxsw-edu-2023/2023/03/07/sxsw-edu-speakers-stress-early-intervention-naloxone-access-to-curb-drug-abuse/</nw:webAddress>
</item>
<item>
<title>Other faculty experts in the media</title>
<link>https://academicexternal.us.newsweaver.com/uthealthnews/1ot29485vlj?lang=en?rss=true</link>
<description></description>
<pubDate>25 Mar 2020 12:00:00 EDT</pubDate>
<guid isPermaLink="false">9d439ad093e1e9838f8c22c885e8fa9a</guid>
<category>In the News</category>
<nw:fullStoryLinkText>Read More</nw:fullStoryLinkText>
<nw:webAddress>https://news.uthscsa.edu/all-news/?wpv_view_count=20070&amp;wpv-category=in-the-news&amp;wpv-health-condition=0&amp;wpv-academic-school=0&amp;wpv-health-service=0&amp;wpv_filter_submit=Submit&amp;utm_source=Newsweaver&amp;utm_medium=email&amp;utm_term=Other+faculty+experts+in+the+media&amp;utm_campaign=uthealthnews</nw:webAddress>
</item>
</channel>
</rss>
